Evidence map›Paper›PMID 41465860›Full record

ReviewLife (Basel, Switzerland)2025

Glial Ion Channels in Myelin Pathophysiology: Insights from Leukodystrophies.

Marcello Belfiore, Sergio Visentin, Elena Ambrosini

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marcello BelfioreNational Center for Preclinical and Clinical Evaluation and Research of Drugs, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy.ORCID 0000-0002-7480-5309
Sergio VisentinNational Center for Preclinical and Clinical Evaluation and Research of Drugs, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy.
Elena AmbrosiniDepartment of Neuroscience, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy.ORCID 0000-0002-4458-3442

Funding

Ministry of University and Research PNRR - M4C2-I1.3 Project PE_00000019
6 · The paper itself

Abstract

Leukodystrophies (LDs) constitute a heterogeneous group of genetic diseases in which mutations in glial cell genes lead to alterations in myelin formation and/or maintenance, ultimately causing white matter dysfunction. Increasing evidence on the genetic basis of LDs has revealed that proteins expressed not only by myelin-forming oligodendrocytes, but also by other glial cell types, play essential roles in myelination. By elucidating disease mechanisms, these studies have uncovered novel cellular and molecular contributors to myelin biogenesis and function, including ion channels. This is exemplified by the recent identification of mutations in the

Indexed as

astrocytesClC-2microglial cellsMLC1oligodendrocytesTMEM63A

Identifiers

PMID41465860
PMCPMC12735030

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.